258 related articles for article (PubMed ID: 7636974)
41. Characterization of the adenoassociated virus Rep protein complex formed on the viral origin of DNA replication.
Li Z; Brister JR; Im DS; Muzyczka N
Virology; 2003 Sep; 313(2):364-76. PubMed ID: 12954205
[TBL] [Abstract][Full Text] [Related]
42. The adeno-associated virus (AAV) Rep protein acts as both a repressor and an activator to regulate AAV transcription during a productive infection.
Pereira DJ; McCarty DM; Muzyczka N
J Virol; 1997 Feb; 71(2):1079-88. PubMed ID: 8995628
[TBL] [Abstract][Full Text] [Related]
43. Adeno-associated viruses having nonsense mutations in the capsid genes: growth in mammalian cells containing an inducible amber suppressor.
Smuda JW; Carter BJ
Virology; 1991 Sep; 184(1):310-8. PubMed ID: 1651593
[TBL] [Abstract][Full Text] [Related]
44. Ubiquitination of both adeno-associated virus type 2 and 5 capsid proteins affects the transduction efficiency of recombinant vectors.
Yan Z; Zak R; Luxton GW; Ritchie TC; Bantel-Schaal U; Engelhardt JF
J Virol; 2002 Mar; 76(5):2043-53. PubMed ID: 11836382
[TBL] [Abstract][Full Text] [Related]
45. Mutational analysis of the adeno-associated virus rep gene.
Yang Q; Kadam A; Trempe JP
J Virol; 1992 Oct; 66(10):6058-69. PubMed ID: 1326656
[TBL] [Abstract][Full Text] [Related]
46. Adeno-associated virus interactions with B23/Nucleophosmin: identification of sub-nucleolar virion regions.
Bevington JM; Needham PG; Verrill KC; Collaco RF; Basrur V; Trempe JP
Virology; 2007 Jan; 357(1):102-13. PubMed ID: 16959286
[TBL] [Abstract][Full Text] [Related]
47. The adeno-associated virus type 2 regulatory proteins rep78 and rep68 interact with the transcriptional coactivator PC4.
Weger S; Wendland M; Kleinschmidt JA; Heilbronn R
J Virol; 1999 Jan; 73(1):260-9. PubMed ID: 9847329
[TBL] [Abstract][Full Text] [Related]
48. Intron splicing-mediated expression of AAV Rep and Cap genes and production of AAV vectors in insect cells.
Chen H
Mol Ther; 2008 May; 16(5):924-30. PubMed ID: 18388928
[TBL] [Abstract][Full Text] [Related]
49. Nuclear transport of trimeric assembly intermediates exerts a morphogenetic control on the icosahedral parvovirus capsid.
Riolobos L; Reguera J; Mateu MG; Almendral JM
J Mol Biol; 2006 Mar; 357(3):1026-38. PubMed ID: 16469332
[TBL] [Abstract][Full Text] [Related]
50. Cryo-electron Microscopy Reconstruction and Stability Studies of the Wild Type and the R432A Variant of Adeno-associated Virus Type 2 Reveal that Capsid Structural Stability Is a Major Factor in Genome Packaging.
Drouin LM; Lins B; Janssen M; Bennett A; Chipman P; McKenna R; Chen W; Muzyczka N; Cardone G; Baker TS; Agbandje-McKenna M
J Virol; 2016 Oct; 90(19):8542-51. PubMed ID: 27440903
[TBL] [Abstract][Full Text] [Related]
51. Encapsidation of adeno-associated virus type 2 Rep proteins in wild-type and recombinant progeny virions: Rep-mediated growth inhibition of primary human cells.
Kube DM; Ponnazhagan S; Srivastava A
J Virol; 1997 Oct; 71(10):7361-71. PubMed ID: 9311814
[TBL] [Abstract][Full Text] [Related]
52. Inhibition of adenovirus cytotoxicity, replication, and E2a gene expression by adeno-associated virus.
Jing XJ; Kalman-Maltese V; Cao X; Yang Q; Trempe JP
Virology; 2001 Dec; 291(1):140-51. PubMed ID: 11878883
[TBL] [Abstract][Full Text] [Related]
53. Selective Rep-Cap gene amplification as a mechanism for high-titer recombinant AAV production from stable cell lines.
Liu X; Voulgaropoulou F; Chen R; Johnson PR; Clark KR
Mol Ther; 2000 Oct; 2(4):394-403. PubMed ID: 11020356
[TBL] [Abstract][Full Text] [Related]
54. The VP1 capsid protein of adeno-associated virus type 2 is carrying a phospholipase A2 domain required for virus infectivity.
Girod A; Wobus CE; Zádori Z; Ried M; Leike K; Tijssen P; Kleinschmidt JA; Hallek M
J Gen Virol; 2002 May; 83(Pt 5):973-978. PubMed ID: 11961250
[TBL] [Abstract][Full Text] [Related]
55. Interaction of wild-type and mutant adeno-associated virus (AAV) Rep proteins on AAV hairpin DNA.
Weitzman MD; Kyöstiö SR; Carter BJ; Owens RA
J Virol; 1996 Apr; 70(4):2440-8. PubMed ID: 8642672
[TBL] [Abstract][Full Text] [Related]
56. Mutations in the carboxy terminus of adeno-associated virus 2 capsid proteins affect viral infectivity: lack of an RGD integrin-binding motif.
Ruffing M; Heid H; Kleinschmidt JA
J Gen Virol; 1994 Dec; 75 ( Pt 12)():3385-92. PubMed ID: 7996133
[TBL] [Abstract][Full Text] [Related]
57. Cross-dressing the virion: the transcapsidation of adeno-associated virus serotypes functionally defines subgroups.
Rabinowitz JE; Bowles DE; Faust SM; Ledford JG; Cunningham SE; Samulski RJ
J Virol; 2004 May; 78(9):4421-32. PubMed ID: 15078923
[TBL] [Abstract][Full Text] [Related]
58. Identification and characterization of nuclear and nucleolar localization signals in the adeno-associated virus serotype 2 assembly-activating protein.
Earley LF; Kawano Y; Adachi K; Sun XX; Dai MS; Nakai H
J Virol; 2015 Mar; 89(6):3038-48. PubMed ID: 25552709
[TBL] [Abstract][Full Text] [Related]
59. Intracellular localization of adeno-associated viral proteins expressed in insect cells.
Gallo-Ramírez LE; Ramírez OT; Palomares LA
Biotechnol Prog; 2011; 27(2):483-93. PubMed ID: 21425251
[TBL] [Abstract][Full Text] [Related]
60. Rep/Cap gene amplification and high-yield production of AAV in an A549 cell line expressing Rep/Cap.
Gao GP; Lu F; Sanmiguel JC; Tran PT; Abbas Z; Lynd KS; Marsh J; Spinner NB; Wilson JM
Mol Ther; 2002 May; 5(5 Pt 1):644-9. PubMed ID: 11991756
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
